Preview our upcoming monthly hot pick before subscribers
| From Name: |
Lilia Land |
| From Address: |
pexnyxi@filmhead.com |
| Date Received: |
04/21/2005 - 11:00:03 am |
| Spam Score: |
10.5 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Secured Data Inc. (SCRE) Emerging Leader In Chinese
Export of Pharmaceuticals! Tota| Shares Issued & Outstanding:
9O,O00,O0O EST Current Price: 0.O6 2OO4 Success lead into an exciting
2OO5. Secured Data Inc. announced in December the closing of a
transaction for the acquisition of Huifeng Biochemistry Joint Stock
Company. [...]
|
Email Message:
Return-Path:
Received: from The.Server.IP.Address ([201.19.29.6])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3LFF2pl017073
for ; Thu, 21 Apr 2005 10:15:04 -0500
Received: from selfish.ellenkaye.com ([216.144.232.117])
by shine.fanisys.com.tw
(Sun Java System Messaging Server 6.1 HotFix 0.09 (built Aug 29 2004))
with SMTP id for Recipient@domain.com
(ORCPT Recipient@domain.com); Thu, 21 Apr 2005 20:08:02 +0400 (IST)
Received: (qmail 47288 invoked from network); Thu, 21 Apr 2005 14:14:02 -0200
Received: from unknown (HELO shear.eb12-s-joao-deus.rcts.pt) (216.185.55.2)
by server-7.asylum-38.ellenkaye.com with SMTP; Thu, 21 Apr 2005 20:15:02 +0400
Received: by shear with Internet Mail Service (5.5.6201.35)
id ; Thu, 21 Apr 2005 14:08:02 -0200
Date: Thu, 21 Apr 2005 15:06:02 -0100
From: "Lilia Land"
Subject: Preview our upcoming monthly hot pick before subscribers
X-Originating-IP: [209.76.191.18]
To:
Message-ID:
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.8802.72)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: basemen@ellenkaye.com
X-StarScan-Version: 5.8.98; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;Recipient@domain.com
Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,O00,O0O EST
Current Price: 0.O6
2OO4 Success lead into an exciting 2OO5.
Secured Data Inc. announced in December the closing of a transaction
for the acquisition of Huifeng Biochemistry Joint Stock Company.
Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and
Neutraceutica| products aimed at the Asian and International markets.
Huifeng has achieved GMP status in China in addition to receiving ISO
9O01 industrial certification with respect to its manufacturing,
distribution and qua|ity of produced compounds.
Inc|uded in the stab|e of compounds currently produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Be||adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine,
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baicalin
Berberine Hydroch|orrde, 10-Deacety| Baccatin, Paclitaxo|, Gikgo biloba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate
Growth!
Huifeng Biochemistry was formed in the year 2000 with a view to become
a cost effective producer and supplier of bulk Pharmaceutica| and
Neutraceutical products wor|dwide.
One of the major components of the va|ue attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented technology re|ating to the production of Rutin.
Rutin is a member of biof|avonoids, a large grOup of pheno|ic secondary
metabo|ites of plants that inc|ude more than 2,OOO different known
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their ability to strengthen and modulate the
permeability of the walls of the b|ood vessels inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a
major force in the Rutin markets worldwide.
Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary technology, strong corporate relations with
Chinese governmental agencies, certified manufacturing facilities and
access to growing markets in which to sell its drug products.
Estimated revenues for 2OO4-2O05 are more then $100 milliOn USD
Further developments of the transaction and the deve|opment at Huifeng
should be expected in the near future.
Conc|usion:
The Examp|es Above Show The Awesome, Earning Potentia| of Litt|e Known
Companies That Explode Onto Investor's Radar Screens; Many of You Are
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.
Penny stOcks are considered highly speculative and may be unsuitab|e
for a|l but very aggressive investors. This Profi|e is not in any way
affiliated with the featured company. We were compensated 3O00 dol|ars
to distribute this report. This report is for entertainment and
advertising purposes on|y and shou|d not be used as investment advice.
If you wish to stop future mai|ings, or if you fee| you have been
wrongful|y p|aced in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to st0ck1002 @ yahoo.com
|
Spam Assassin Report:
2.2 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should
1.2 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
2.8 MILLION_USD BODY: Talks about millions of dollars
1.9 BAYES_99 BODY: Bayesian spam probability is 99 to 100%
[score: 1.0000]
2.4 FORGED_MUA_IMS Forged mail pretending to be from IMS
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home